CD8A and neoplasm: We have demonstrated that LDH-A deletion in myeloid cells boosts anti-tumor T cell immunity through induction of IL-17-producing CD8+ T (Tc17) cells, likely via suppression of the lactate-driven PDL-1 expression (6).